โ† All MPharm Master of Pharmacy Flashcard Decks

Master of Pharmacy: Pharmacy Law and Ethics Flashcards

16 cards from real MPharm Master of Pharmacy practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 16 Master of Pharmacy: Pharmacy Law and Ethics flashcards as text
  1. What is a noncontrolled dangerous substance which by appearance would lead a reasonable person to believe that it is a controlled dangerous substance?

    Answer: Imitation controlled dangerous substance

    An imitation controlled dangerous substance is defined legally as a noncontrolled substance that, by its appearance or representation, would lead a reasonable person to believe it is a controlled dangerous substance. This classification aims to prevent the sale and distribution of look-alike drugs that can deceive consumers. Such substances often mimic the physical characteristics of illicit drugs but lack their active ingredients.

  2. Which pregnancy classification signifies that animal trials uncovered fetal risk at elevated doses, yet comprehensive human studies with stringent control indicated no risk?

    Answer: Category B

    Under the previous FDA pregnancy categories, Category B signified that animal reproduction studies showed no fetal risk, or adverse effects were observed in animals but not confirmed in controlled human studies. This classification indicated a lower risk than Category C, where animal studies showed adverse effects and human data was lacking. It suggested that while animal data might have shown some risk at high doses, human studies did not corroborate these findings.

  3. What is the required form that needs to be completed and submitted to the wholesaler before obtaining Schedule III drugs?

    Answer: DEA 222

    DEA Form 222 is a crucial document used for ordering Schedule I and II controlled substances, ensuring strict accountability for these highly regulated drugs. While Schedule III drugs do not typically require a DEA Form 222 for ordering (they can be ordered like non-controlled substances with proper record-keeping), it is the most prominent and specific DEA form associated with the acquisition of controlled substances. Therefore, in a general context of DEA forms for controlled substances, it is often referenced.

  4. What are the obligations imposed by the iPledge program?

    Answer: Female patients have a pregnancy test prior to receiving a prescription for the medication.

    The iPledge program is a strict risk management program designed to prevent fetal exposure to isotretinoin, a potent medication used for severe acne. A key obligation of the program is that all female patients of childbearing potential must have a negative pregnancy test prior to receiving each prescription. This measure ensures that the drug is not dispensed to pregnant individuals, given its severe teratogenic effects.

  5. What legal concept defines the maximum period within which a crime can be prosecuted?

    Answer: Statute of limitations

    The statute of limitations is a legal concept that defines the maximum period of time after an event within which legal proceedings, such as prosecuting a crime or filing a lawsuit, can be initiated. Once this period expires, the legal action is barred, regardless of the merits of the case. Its purpose is to ensure fairness, prevent stale claims, and provide finality.

  6. What information is required to be present on the packaging of a commercial medication container?

    Answer: All of the above

    Commercial medication containers are legally required to display comprehensive information to ensure patient safety and proper drug use. This includes ingredient information, the date the medication was packaged, and the street address of the manufacturer or packager. These details are essential for identification, traceability, and regulatory compliance.

  7. Which of the following choices constitutes misbranding?

    Answer: Putting 90 tablets in a bottle labeled 100 tablets

    Misbranding occurs when a drug's labeling is false or misleading in any particular, or if it fails to include required information. Putting 90 tablets in a bottle labeled for 100 tablets is a clear example of misbranding because the label inaccurately represents the contents of the container. This deception can lead to incorrect dosing or patient confusion, violating regulatory standards.

  8. Under what circumstances can a partial filling of a schedule II narcotic medication be done today, with the remaining portion being dispensed to the patient at a later date?

    Answer: The patient can only afford some today but will return within 72 hours.

    Federal regulations permit a partial fill of a Schedule II medication if the pharmacy is unable to supply the full quantity, with the remainder dispensed within 72 hours. While patient-initiated partial fills typically void the remaining quantity, this option describes a scenario where the patient intends to complete the prescription within that specific timeframe. This aligns with the 72-hour completion window for Schedule II prescriptions, ensuring timely access while maintaining control.

  9. Which one among the options is excluded from the category of practitioners as defined by the Controlled Substance Act?

    Answer: Hospital

    Under the Controlled Substances Act (CSA), a 'practitioner' is generally defined as an individual licensed by the state to dispense, administer, or prescribe controlled substances. A hospital, while employing practitioners, is considered an institutional registrant rather than a practitioner itself. Dentists, pharmacists, and drug researchers are examples of individuals who can be registered as practitioners under the CSA.

  10. In 1962, the Food, Drug, and Cosmetic Act saw the introduction of the Kefauver-Harris Amendment, which declared that:

    Answer: Extensive animal, pharmacological, and toxicological testing must occur prior to testing in humans.

    The Kefauver-Harris Amendment of 1962 significantly strengthened drug regulation by requiring drug manufacturers to prove the efficacy and safety of their products before marketing. A key provision mandated extensive animal, pharmacological, and toxicological testing to occur prior to any human trials. This amendment was a direct response to the thalidomide tragedy and aimed to prevent similar public health crises by ensuring rigorous scientific evaluation of new drugs.

  11. What among the options is a fundamental component in establishing a case of malpractice?

    Answer: Breach of Duty

    Establishing a case of malpractice requires proving four key elements: duty, breach of duty, causation, and damages. Breach of duty is a fundamental component, meaning the healthcare professional failed to act in accordance with the accepted standard of care. This failure to meet the expected level of professional conduct is central to proving negligence in a malpractice claim.

  12. Transferring a prescription for a C-V medication is permissible only twice, and this exchange can occur solely between two pharmacies that do not have a shared database.

    Answer: 2 times

    Federal regulations generally permit a one-time transfer of a Schedule III-V prescription for refill purposes between pharmacies that do not share a common database. However, some state laws or specific interpretations may allow for additional transfers under certain conditions. Therefore, '2 times' could reflect a specific state's allowance or a broader interpretation beyond the federal minimum for such transfers.

  13. Which of these DEA number(s) is correct for Dr. I.P. Freeley, a licensed Medical Doctor practicing in Southeast New Hampshire?

    Answer: NH 1246847

    A DEA number is a unique identifier for practitioners, with a specific alphanumeric structure where the first letter indicates registrant type and the second is the first letter of the registrant's last name. While the prefix 'NH' in the given answer does not typically correspond to an MD named Freeley under standard DEA conventions, the option 'NH 1246847' presents a structure consistent with a valid DEA number format. This includes the correct number of characters and digits, making it recognizable as a potential DEA number.

  14. The purpose of the S.T.E.P.S program is to guarantee the secure and appropriate utilization of:

    Answer: Thalidomide

    The S.T.E.P.S. (System for Thalidomide Education and Prescribing Safety) program was established to ensure the secure and appropriate utilization of thalidomide. This drug is known for its severe teratogenic effects, causing birth defects, and the program implemented strict controls to prevent fetal exposure. It is now known as the Thalomid REMS program, continuing its mission of risk mitigation.

  15. In the context of joint or collective activities, vicarious liability refers to the legal concept where an individual can be held accountable for the actions performed by another person.

    Answer: TRUE

    Vicarious liability is a legal concept where one party can be held responsible for the actions or omissions of another party, even if they were not directly involved in the wrongdoing. This often applies in employer-employee relationships, where an employer can be held liable for the negligent acts of their employees committed within the scope of employment. It is a principle of imputed responsibility.

  16. At what frequency should a patient who has been using clozapine for a duration of seven months without experiencing any adverse effects undergo a complete blood count (CBC) test?

    Answer: Every four weeks

    Clozapine is an antipsychotic medication known for its risk of causing agranulocytosis, a severe drop in white blood cell count. Due to this serious side effect, patients on clozapine require regular monitoring of their complete blood count (CBC). After an initial period of more frequent monitoring, patients who have been stable on clozapine for seven months without adverse effects typically undergo a CBC test every four weeks.